Insider · CIK 0001253170
Srinivas Akkaraju
Files at VTVT (vTv Therapeutics Inc.), SRRK (Scholar Rock Holding Corp), KLRS (Kalaris Therapeutics, Inc.), ALMS (ALUMIS INC.), MLYS (Mineralys Therapeutics, Inc.). First filing Mar 17, 2025, latest Sep 9, 2026.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
ALMS: ALUMIS INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
MLYS: Mineralys Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | ALMSbuy ALUMIS INC. | $11M 986,721 shares | +22% | - | |
| 40Moderate | ALMSsell ALUMIS INC. | $1.0M 96,131 shares | -2% | - | |
| 66Notable | ALUMIS INC. | $1.5M 320,290 shares | +10% | +29% from low-65% from high | |
| 58Moderate | Mineralys Therapeutics, Inc. | $8.1M 600,000 shares | +12% | +54% from low-10% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | ALMS ALUMIS INC. | POpen-market purchase Common Stockindirect: By Samsara BioCapital, L.P. | +220,070 | $11.17 | $2.5M | 4,711,801 | 33 d ago |
| Sep 4, 2026 | ALMS ALUMIS INC. | POpen-market purchase Common Stockindirect: By Samsara Opportunity Fund, L.P. | +220,070 | $11.17 | $2.5M | 2,073,558 | 33 d ago |
| Sep 8, 2026 | ALMS ALUMIS INC. | SOpen-market sale Common Stockindirect: By Samsara BioCapital, L.P. | -48,066 | $10.55 | $507k | 4,663,735 | 33 d ago |
| Sep 8, 2026 | ALMS ALUMIS INC. | SOpen-market sale Common Stockindirect: By Samsara Opportunity Fund, L.P. | -48,065 | $10.55 | $507k | 2,025,493 | 33 d ago |
| Sep 8, 2026 | ALMS ALUMIS INC. | POpen-market purchase Common Stockindirect: By Samsara BioCapital, L.P. | +273,291 | $10.63 | $2.9M | 4,937,026 | 33 d ago |
| Sep 8, 2026 | ALMS ALUMIS INC. | POpen-market purchase Common Stockindirect: By Samsara Opportunity Fund, L.P. | +273,290 | $10.63 | $2.9M | 2,298,783 | 33 d ago |
| Jun 10, 2025 | VTVT vTv Therapeutics Inc. | AGrant or award Director stock option (right to buy)derivative | +4,000 | $16.59 | $66k | 10,983 | Jun 12, 2025 |
| May 22, 2025 | SRRK Scholar Rock Holding Corp | AGrant or award Common Stock | +7,632 | $0.00 | $0 | 21,132 | May 23, 2025 |
| May 21, 2025 | ALMS ALUMIS INC. | AGrant or award Common Stockindirect: By Samsara BioCapital, L.P. | +1,214,582 | - | - | 4,801,370 | May 23, 2025 |
| May 22, 2025 | SRRK Scholar Rock Holding Corp | AGrant or award Stock Option (Right to Buy)derivative | +9,206 | $0.00 | $0 | 9,206 | May 23, 2025 |
| May 2, 2025 | ALMS ALUMIS INC. | POpen-market purchase Common Stockindirect: By Samsara BioCapital, L.P. | +159,920 | $4.55 | $728k | 3,426,418 | May 6, 2025 |
| May 5, 2025 | ALMS ALUMIS INC. | POpen-market purchase Common Stockindirect: By Samsara BioCapital, L.P. | +138,368 | $4.58 | $634k | 3,564,786 | May 6, 2025 |
| May 5, 2025 | ALMS ALUMIS INC. | POpen-market purchase Common Stockindirect: By Samsara BioCapital, L.P. | +22,002 | $5.27 | $116k | 3,586,788 | May 6, 2025 |
| Jun 25, 2024 | VTVT vTv Therapeutics Inc. | AGrant or award Director stock option (right to buy)derivative | +2,250 | $17.22 | $39k | 6,000 | Apr 24, 2025 |
| Jun 25, 2024 | VTVT vTv Therapeutics Inc. | AGrant or award Director stock option (right to buy)derivative | +983 | $17.22 | $17k | 6,983 | Apr 24, 2025 |
| Apr 10, 2025 | KLRS Kalaris Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +18,000 | $0.00 | $0 | 18,000 | Apr 11, 2025 |
| Mar 18, 2025 | KLRS Kalaris Therapeutics, Inc. | AGrant or award Common Stockindirect: See footnote | +11,444,503 | - | - | 11,444,503 | Mar 18, 2025 |
| Mar 13, 2025 | MLYS Mineralys Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Samsara BioCapital, L.P. | +600,000 | $13.50 | $8.1M | 5,674,916 | Mar 17, 2025 |
| Feb 13, 2025 | MLYS Mineralys Therapeutics, Inc. | AGrant or award Stock Optionderivative | +32,900 | $0.00 | $0 | 32,900 | Feb 24, 2025 |
| Mar 5, 2024 | VTVT vTv Therapeutics Inc. | DDisposition to issuer Class A Common Stockindirect: By Samsara BioCapital, L.P. | -58,836 | - | - | 206,784 | Dec 6, 2024 |
| Mar 5, 2024 | VTVT vTv Therapeutics Inc. | AGrant or award Pre- Funded Warrants (Right to Buy)derivativeindirect: Samsara BioCapital, L.P. | +58,885 | - | - | 892,578 | Dec 6, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.